Walker Neal

Walker Neal is listed in filings as CEO at Aclaris Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2026, including 38 public disclosures. Recent filings connect the profile to Aclaris Therapeutics, Inc. (ACRS) and Aldeyra Therapeutics, Inc. (ALDX). The current snapshot covers public activity from Jul 3, 2024 to Feb 6, 2026. Reported amounts are shown as $64.6K to $28.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.